<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2011-05-31" modified="2024-01-24" version="24" xmlns="http://uniprot.org/uniprot">
  <accession>B5MFD0</accession>
  <name>LANNA_STAHO</name>
  <protein>
    <recommendedName>
      <fullName evidence="1">Lantibiotic nukacin</fullName>
    </recommendedName>
    <alternativeName>
      <fullName>Nukacin KQ-1</fullName>
    </alternativeName>
    <alternativeName>
      <fullName evidence="4">Nukacin KQU-131</fullName>
    </alternativeName>
  </protein>
  <gene>
    <name evidence="1" type="primary">nukA</name>
    <name evidence="6" type="synonym">nkqA</name>
  </gene>
  <organism>
    <name type="scientific">Staphylococcus hominis</name>
    <dbReference type="NCBI Taxonomy" id="1290"/>
    <lineage>
      <taxon>Bacteria</taxon>
      <taxon>Bacillota</taxon>
      <taxon>Bacilli</taxon>
      <taxon>Bacillales</taxon>
      <taxon>Staphylococcaceae</taxon>
      <taxon>Staphylococcus</taxon>
    </lineage>
  </organism>
  <reference evidence="5 6" key="1">
    <citation type="journal article" date="2008" name="Biosci. Biotechnol. Biochem." volume="72" first="2232" last="2235">
      <title>Identification of the nukacin KQU-131, a new type-A(II) lantibiotic produced by Staphylococcus hominis KQU-131 isolated from Thai fermented fish product (Pla-ra).</title>
      <authorList>
        <person name="Wilaipun P."/>
        <person name="Zendo T."/>
        <person name="Okuda K."/>
        <person name="Nakayama J."/>
        <person name="Sonomoto K."/>
      </authorList>
      <dbReference type="PubMed" id="18685189"/>
      <dbReference type="DOI" id="10.1271/bbb.80239"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
    <scope>PROTEIN SEQUENCE OF 31-38</scope>
    <scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
    <scope>MASS SPECTROMETRY</scope>
    <source>
      <strain evidence="3">KQU-131</strain>
    </source>
  </reference>
  <comment type="function">
    <text evidence="1">Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores (By similarity).</text>
  </comment>
  <comment type="biophysicochemical properties">
    <temperatureDependence>
      <text evidence="3">Retains 50% of its antimicrobial activity after heating at 100 degrees Celsius for 100 minutes, and retains 25% antimicrobial activity after heating at 121 Celsius for 15 minutes.</text>
    </temperatureDependence>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location evidence="1">Secreted</location>
    </subcellularLocation>
    <text evidence="1">Through the specific ABC transporter nukT.</text>
  </comment>
  <comment type="PTM">
    <text evidence="1">Maturation of lantibiotics involves the enzymatic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. This is followed by membrane translocation and cleavage of the modified precursor (By similarity).</text>
  </comment>
  <comment type="mass spectrometry" mass="3003.97" method="Electrospray" evidence="3"/>
  <comment type="similarity">
    <text evidence="2">Belongs to the type A lantibiotic family.</text>
  </comment>
  <dbReference type="EMBL" id="AB432987">
    <property type="protein sequence ID" value="BAG70955.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="AlphaFoldDB" id="B5MFD0"/>
  <dbReference type="SMR" id="B5MFD0"/>
  <dbReference type="TCDB" id="1.C.21.1.8">
    <property type="family name" value="the lacticin 481 (lacticin 481) family"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005576">
    <property type="term" value="C:extracellular region"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-SubCell"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005102">
    <property type="term" value="F:signaling receptor binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042742">
    <property type="term" value="P:defense response to bacterium"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0031640">
    <property type="term" value="P:killing of cells of another organism"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR007682">
    <property type="entry name" value="Lantibiotic_typ-A_Lactobact"/>
  </dbReference>
  <dbReference type="NCBIfam" id="NF040664">
    <property type="entry name" value="HEC_x9_TCC_lant"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF04604">
    <property type="entry name" value="L_biotic_typeA"/>
    <property type="match status" value="1"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0044">Antibiotic</keyword>
  <keyword id="KW-0929">Antimicrobial</keyword>
  <keyword id="KW-0078">Bacteriocin</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0425">Lantibiotic</keyword>
  <keyword id="KW-0964">Secreted</keyword>
  <keyword id="KW-0883">Thioether bond</keyword>
  <feature type="propeptide" id="PRO_0000408769" evidence="3">
    <location>
      <begin position="1"/>
      <end position="30"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000408770" description="Lantibiotic nukacin" evidence="3">
    <location>
      <begin position="31"/>
      <end position="57"/>
    </location>
  </feature>
  <feature type="modified residue" description="2,3-didehydrobutyrine" evidence="1">
    <location>
      <position position="54"/>
    </location>
  </feature>
  <feature type="cross-link" description="Beta-methyllanthionine (Thr-Cys)" evidence="1">
    <location>
      <begin position="39"/>
      <end position="44"/>
    </location>
  </feature>
  <feature type="cross-link" description="Lanthionine (Ser-Cys)" evidence="1">
    <location>
      <begin position="41"/>
      <end position="55"/>
    </location>
  </feature>
  <feature type="cross-link" description="Beta-methyllanthionine (Thr-Cys)" evidence="1">
    <location>
      <begin position="48"/>
      <end position="56"/>
    </location>
  </feature>
  <evidence type="ECO:0000250" key="1">
    <source>
      <dbReference type="UniProtKB" id="Q9KWM4"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="2"/>
  <evidence type="ECO:0000269" key="3">
    <source>
      <dbReference type="PubMed" id="18685189"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="4">
    <source>
      <dbReference type="PubMed" id="18685189"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="5"/>
  <evidence type="ECO:0000312" key="6">
    <source>
      <dbReference type="EMBL" id="BAG70955.1"/>
    </source>
  </evidence>
  <sequence length="57" mass="6463" checksum="9BF6DF7549E0A5F6" modified="2008-11-04" version="1" precursor="true">MENSKIMKDIEVANLLEEVQEDELNEVLGAKKKSGVIPTVSHDCHMNTFQFMFTCCS</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>